Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Clinical Meanings of Quantitative PCR of Patient-Specific Immunoglobulin VDJ Regions Using Various Materials of Myeloma Patients

Blood (2014) 124 (21): 2049.

https://doi.org/10.1182/blood.V124.21.2049.2049

Published: 2014

Journal Articles

αIIb(R990W), a Constitutive Activating Mutation of Integrin αIIbβ3, Knock-in Mice Show Macrothrombocytopenia with Impairment of Platelet Function

Kazunobu Kiyomizu, Hirokazu Kashiwagi, Shinji Kunishima, PhD, Fumiaki Banno, PhD, Hisashi Kato, Youichiro Morikawa, Seiji Tadokoro, Koichi Kokame, PhD, Shigenori Honda, MD PhD, Toshiyuki Miyata, PhD, Yuzuru Kanakura, Yoshiaki Tomiyama

Blood (2014) 124 (21): 4182.

https://doi.org/10.1182/blood.V124.21.4182.4182

Published: 2014

Journal Articles

Final Results From SENSOR: Switch to Nilotinib After Molecular Suboptimal Response (SoR) to Frontline Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Blood (2014) 124 (21): 1815.

https://doi.org/10.1182/blood.V124.21.1815.1815

Published: 2014

Journal Articles

Nilotinib Following Molecular Suboptimal Response (SoR) To Imatinib In Japanese Patients (pts) With Chronic Myeloid Leukemia In Chronic Phase (CML-CP): 12 Month Follow-Up From The SENSOR Study

Blood (2013) 122 (21): 2729.

https://doi.org/10.1182/blood.V122.21.2729.2729

Published: 2013

Journal Articles

Recognition of highly restricted regions in the β-propeller domain of αIIb by platelet-associated anti-αIIbβ3 autoantibodies in primary immune thrombocytopenia

Kazunobu Kiyomizu, Hirokazu Kashiwagi, Tsuyoshi Nakazawa, Seiji Tadokoro, Shigenori Honda, Yuzuru Kanakura, Yoshiaki Tomiyama

Blood (2012) 120 (7): 1499–1509.

https://doi.org/10.1182/blood-2012-02-409995

Published: 2012

Includes: Supplemental data

Journal Articles

Agonist Stimulation, Talin-1, and Kindlin-3 Are Crucial for α ¶b β 3 activation in a Human Megakaryoblastic Cell Line, CMK

Tsuyoshi Nakazawa, Seiji Tadokoro, Kazunobu Kiyomizu, Hirokazu Kashiwagi, Shigenori Honda, Yoshiaki Tomiyama, Yuzuru Kanakura

Blood (2011) 118 (21): 1137.

https://doi.org/10.1182/blood.V118.21.1137.1137

Published: 2011

Journal Articles

A potential role for α-actinin in inside-out αIIbβ3 signaling

Seiji Tadokoro, Tsuyoshi Nakazawa, Tsuyoshi Kamae, Kazunobu Kiyomizu, Hirokazu Kashiwagi, Shigenori Honda, Yuzuru Kanakura, Yoshiaki Tomiyama

Blood (2011) 117 (1): 250–258.

https://doi.org/10.1182/blood-2009-10-246751

Published: 2011

Includes: Supplemental data

Journal Articles

Bleeding Tendency and Impaired Platelet Function In a Patient Carrying a Heterozygous Mutation In Thromboxane A2 Receptor

Tsuyoshi Kamae, MD, Kazunobu Kiyomizu, MD, Tsuyoshi Nakazawa, MD, Seiji Tadokoro, MD, Shigenori Honda, MD, Hirokazu Kashiwagi, MD, Yuzuru Kanakura, MD, PhD, Yoshiaki Tomiyama, MD

Blood (2010) 116 (21): 2524.

https://doi.org/10.1182/blood.V116.21.2524.2524

Published: 2010

Journal Articles

Integrin-linked kinase associated with integrin activation

Shigenori Honda, Hiroko Shirotani-Ikejima, Seiji Tadokoro, Yusuke Maeda, Taroh Kinoshita, Yoshiaki Tomiyama, Toshiyuki Miyata

Blood (2009) 113 (21): 5304–5313.

https://doi.org/10.1182/blood-2008-07-169136

Published: 2009

Journal Articles

A Role for α-Actinin in Inside-out αIIbβ3 Signaling.

Seiji Tadokoro, Masamichi Shiraga, Hirokazu Kashiwagi, Tsuyoshi Kamae, Masao Akiyama, Tsuyoshi Nakazawa, Yuzuru Kanakura, Yoshiaki Tomiyama

Blood (2008) 112 (11): 1849.

https://doi.org/10.1182/blood.V112.11.1849.1849

Published: 2008

Journal Articles

P2Y 12 -Independent Transient Activation and P2Y 12 -Dependent Prolonged Activation of Platelet Integrin α IIb β 3 .

Masamichi Shiraga, MD, Tsuyoshi Kamae, MD, Masao Akiyama, MD, Seiji Tadokoro, MD, Hirokazu Kashiwagi, MD, Kenji Oritani, MD, Yoshiyuki Kurata, MD, Yoshiaki Tomiyama, MD, Yuzuru Kanakura, MD

Blood (2006) 108 (11): 1509.

https://doi.org/10.1182/blood.V108.11.1509.1509

Published: 2006

Journal Articles

Critical Role of Endogenous ADP Via P2Y12 Receptor in Maintenance of α Iib β 3 Activation.

Tsuyoshi Kamae, MD, Masamichi Shiraga, MD, Hirokazu Kashiwagi, MD, Hisashi Kato, MD, Seiji Tadokoro, MD, Yoshiyuki Kurata, MD, Yoshiaki Tomiyama, MD, Yuzuru Kanakura, MD

Blood (2005) 106 (11): 1655.

https://doi.org/10.1182/blood.V106.11.1655.1655

Published: 2005

Journal Articles

Negative regulation of platelet function by a secreted cell repulsive protein, semaphorin 3A

Hirokazu Kashiwagi, Masamichi Shiraga, Hisashi Kato, Tsuyoshi Kamae, Naoko Yamamoto, Seiji Tadokoro, Yoshiyuki Kurata, Yoshiaki Tomiyama, Yuzuru Kanakura

Blood (2005) 106 (3): 913–921.

https://doi.org/10.1182/blood-2004-10-4092

Published: 2005

Journal Articles

Negative Regulation of Platelet Function by a Secreted Cell Repulsive Protein, Semaphorin 3A.

Hirokazu Kashiwagi, MD, Masamichi Shiraga, MD, Hisashi Kato, MD, Tsuyoshi Kamae, MD, Naoko Yamamoto, MD, Seiji Tadokoro, MD, Yoshiyuki Kurata, MD, Yoshiaki Tomiyama, MD, Yuzuru Kanakura, MD, PhD

Blood (2004) 104 (11): 1546.

https://doi.org/10.1182/blood.V104.11.1546.1546

Published: 2004

Journal Articles

A naturally occurring Tyr143Hisα IIb mutation abolishes α IIb β 3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand-binding defects

Teruo Kiyoi, Yoshiaki Tomiyama, Shigenori Honda, Seiji Tadokoro, Morio Arai, Hirokazu Kashiwagi, Satoru Kosugi, Hisashi Kato, Yoshiyuki Kurata, Yuji Matsuzawa

Blood (2003) 101 (9): 3485–3491.

https://doi.org/10.1182/blood-2002-07-2144

Published: 2003

Journal Articles

Missense mutations in the β 3 subunit have a different impact on the expression and function between α IIb β 3 and α v β 3

Seiji Tadokoro, Yoshiaki Tomiyama, Shigenori Honda, Hirokazu Kashiwagi, Satoru Kosugi, Masamichi Shiraga, Teruo Kiyoi, Yoshiyuki Kurata, Yuji Matsuzawa

Blood (2002) 99 (3): 931–938.

https://doi.org/10.1182/blood.V99.3.931

Published: 2002

Journal Articles

Ligand binding to integrin α v β 3 requires tyrosine 178 in the α v subunit

Shigenori Honda, Yoshiaki Tomiyama, Nisar Pampori, Hirokazu Kashiwagi, Teruo Kiyoi, Satoru Kosugi, Seiji Tadokoro, Yoshiyuki Kurata, Sanford J. Shattil, Yuji Matsuzawa

Blood (2001) 97 (1): 175–182.

https://doi.org/10.1182/blood.V97.1.175

Published: 2001

Journal Articles

A Mutation in the Extracellular Cysteine-Rich Repeat Region of the β 3 Subunit Activates Integrins  IIb β 3 and  V β 3

Hirokazu Kashiwagi, Yoshiaki Tomiyama, Seiji Tadokoro, Shigenori Honda, Masamichi Shiraga, Hajime Mizutani, Makoto Handa, Yoshiyuki Kurata, Yuji Matsuzawa, Sanford J. Shattil

Blood (1999) 93 (8): 2559–2568.

https://doi.org/10.1182/blood.V93.8.2559

Published: 1999

Journal Articles

Involvement of Na + /Ca 2+ Exchanger in Inside-Out Signaling Through the Platelet Integrin  IIb β 3

Masamichi Shiraga, Yoshiaki Tomiyama, Shigenori Honda, Hidenori Suzuki, Satoru Kosugi, Seiji Tadokoro, Yuzuru Kanakura, Kenjiro Tanoue, Yoshiyuki Kurata, Yuji Matsuzawa

Blood (1998) 92 (10): 3710–3720.

https://doi.org/10.1182/blood.V92.10.3710

Published: 1998

Journal Articles

A Gln747→Pro Substitution in the  IIb Subunit Is Responsible for a Moderate  IIb β 3 Deficiency in Glanzmann Thrombasthenia

Seiji Tadokoro, Yoshiaki Tomiyama, Shigenori Honda, Morio Arai, Naomasa Yamamoto, Masamichi Shiraga, Satoru Kosugi, Yuzuru Kanakura, Yoshiyuki Kurata, Yuji Matsuzawa

Blood (1998) 92 (8): 2750–2758.

https://doi.org/10.1182/blood.V92.8.2750

Published: 1998

NARROW

Clinical Meanings of Quantitative PCR of Patient-Specific Immunoglobulin VDJ Regions Using Various Materials of Myeloma Patients

αIIb(R990W), a Constitutive Activating Mutation of Integrin αIIbβ3, Knock-in Mice Show Macrothrombocytopenia with Impairment of Platelet Function

Final Results From SENSOR: Switch to Nilotinib After Molecular Suboptimal Response (SoR) to Frontline Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Nilotinib Following Molecular Suboptimal Response (SoR) To Imatinib In Japanese Patients (pts) With Chronic Myeloid Leukemia In Chronic Phase (CML-CP): 12 Month Follow-Up From The SENSOR Study

Recognition of highly restricted regions in the β-propeller domain of αIIb by platelet-associated anti-αIIbβ3 autoantibodies in primary immune thrombocytopenia

Agonist Stimulation, Talin-1, and Kindlin-3 Are Crucial for α ¶b β 3 activation in a Human Megakaryoblastic Cell Line, CMK

A potential role for α-actinin in inside-out αIIbβ3 signaling

Bleeding Tendency and Impaired Platelet Function In a Patient Carrying a Heterozygous Mutation In Thromboxane A2 Receptor

Integrin-linked kinase associated with integrin activation

A Role for α-Actinin in Inside-out αIIbβ3 Signaling.

P2Y 12 -Independent Transient Activation and P2Y 12 -Dependent Prolonged Activation of Platelet Integrin α IIb β 3 .

Critical Role of Endogenous ADP Via P2Y12 Receptor in Maintenance of α Iib β 3 Activation.

Negative regulation of platelet function by a secreted cell repulsive protein, semaphorin 3A

Negative Regulation of Platelet Function by a Secreted Cell Repulsive Protein, Semaphorin 3A.

A naturally occurring Tyr143Hisα IIb mutation abolishes α IIb β 3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand-binding defects

Missense mutations in the β 3 subunit have a different impact on the expression and function between α IIb β 3 and α v β 3

Ligand binding to integrin α v β 3 requires tyrosine 178 in the α v subunit

A Mutation in the Extracellular Cysteine-Rich Repeat Region of the β 3 Subunit Activates Integrins  IIb β 3 and  V β 3

Involvement of Na + /Ca 2+ Exchanger in Inside-Out Signaling Through the Platelet Integrin  IIb β 3

A Gln747→Pro Substitution in the  IIb Subunit Is Responsible for a Moderate  IIb β 3 Deficiency in Glanzmann Thrombasthenia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only